Cargando…
Should women under 50 be screened for breast cancer?
Despite some controversy in recent years, the majority of experts agree on the evidence for effectiveness of breast screening by mammography for women aged 50 years and above, but for those under 50 years, the picture is much less clear. However, the issue remains of importance both to policy makers...
Autor principal: | |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409834/ https://www.ncbi.nlm.nih.gov/pubmed/15213718 http://dx.doi.org/10.1038/sj.bjc.6601966 |
_version_ | 1782155875807395840 |
---|---|
author | Moss, S |
author_facet | Moss, S |
author_sort | Moss, S |
collection | PubMed |
description | Despite some controversy in recent years, the majority of experts agree on the evidence for effectiveness of breast screening by mammography for women aged 50 years and above, but for those under 50 years, the picture is much less clear. However, the issue remains of importance both to policy makers and to individual women; although the incidence of breast cancer is lower at younger ages, the life years lost due to cancers diagnosed below 50 years amount to a third of all those lost due to the disease. |
format | Text |
id | pubmed-2409834 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2004 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-24098342009-09-10 Should women under 50 be screened for breast cancer? Moss, S Br J Cancer Minireview Despite some controversy in recent years, the majority of experts agree on the evidence for effectiveness of breast screening by mammography for women aged 50 years and above, but for those under 50 years, the picture is much less clear. However, the issue remains of importance both to policy makers and to individual women; although the incidence of breast cancer is lower at younger ages, the life years lost due to cancers diagnosed below 50 years amount to a third of all those lost due to the disease. Nature Publishing Group 2004-08-02 2004-06-22 /pmc/articles/PMC2409834/ /pubmed/15213718 http://dx.doi.org/10.1038/sj.bjc.6601966 Text en Copyright © 2004 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Minireview Moss, S Should women under 50 be screened for breast cancer? |
title | Should women under 50 be screened for breast cancer? |
title_full | Should women under 50 be screened for breast cancer? |
title_fullStr | Should women under 50 be screened for breast cancer? |
title_full_unstemmed | Should women under 50 be screened for breast cancer? |
title_short | Should women under 50 be screened for breast cancer? |
title_sort | should women under 50 be screened for breast cancer? |
topic | Minireview |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409834/ https://www.ncbi.nlm.nih.gov/pubmed/15213718 http://dx.doi.org/10.1038/sj.bjc.6601966 |
work_keys_str_mv | AT mosss shouldwomenunder50bescreenedforbreastcancer |